Expert Consensus on Tiered Diagnosis and Treatment of Breast Cancer as a Single‐Disease Management Model in China (2025 Edition)

Breast cancer is the most prevalent female malignancy worldwide. In 2022, China recorded approximately 357,000 new breast cancer cases and 75,000 deaths, posing a serious threat to female health. Given the "inverted pyramid" structure of China's healthcare system in service provision and resource distribution, there is an urgent need to establish a rational medical service framework that can optimize resource allocation, ensure patients receive appropriate diagnosis and treatment at different stages, and strengthen patient-centered continuity of care, thereby enhancing overall therapeutic outcomes. Under the tiered diagnosis and treatment framework, the Breast Cancer Expert Committee of the National Cancer Quality Control Center and the National Health Development Research Center of the National Health Commission have jointly drafted and formulated this <i>Expert Consensus on Tiered Diagnosis and Treatment of Breast Cancer as a Single-disease Management Model of Breast Cancer in China (2025 Edition)</i> to clarify the functional roles of different tiers of healthcare institutions, rationally allocate medical resources, and establish an integrated healthcare service system. This system emphasizes primary care, two-way referrals, differentiated management of acute and chronic conditions, and coordinated multi-level collaboration. The goal is to optimize comprehensive breast cancer management, spanning prevention, screening, diagnosis, treatment, and rehabilitation, ultimately improving patient survival and quality of life.

Authors

Institutions

Publication Details

Journal
Cancer Innovation
Published
2025-10-01
DOI
https://doi.org/10.1002/cai2.70031
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Expert Consensus on Tiered Diagnosis and Treatment of Breast Cancer as a Single‐Disease Management Model in China (2025 Edition)

Fei Ma, Erdan Huang, Shuping Wang, Jiani Wang
Cancer Innovation
Cancer Genomics and Diagnostics
article

Expert Consensus on Tiered Diagnosis and Treatment of Breast Cancer as a Single‐Disease Management Model in China (2025 Edition)

Fei Ma, Erdan Huang, Shuping Wang, Jiani Wang
article en

Abstract

Breast cancer is the most prevalent female malignancy worldwide. In 2022, China recorded approximately 357,000 new breast cancer cases and 75,000 deaths, posing a serious threat to female health. Given the "inverted pyramid" structure of China's healthcare system in service provision and resource distribution, there is an urgent need to establish a rational medical service framework that can optimize resource allocation, ensure patients receive appropriate diagnosis and treatment at different stages, and strengthen patient-centered continuity of care, thereby enhancing overall therapeutic outcomes. Under the tiered diagnosis and treatment framework, the Breast Cancer Expert Committee of the National Cancer Quality Control Center and the National Health Development Research Center of the National Health Commission have jointly drafted and formulated this <i>Expert Consensus on Tiered Diagnosis and Treatment of Breast Cancer as a Single-disease Management Model of Breast Cancer in China (2025 Edition)</i> to clarify the functional roles of different tiers of healthcare institutions, rationally allocate medical resources, and establish an integrated healthcare service system. This system emphasizes primary care, two-way referrals, differentiated management of acute and chronic conditions, and coordinated multi-level collaboration. The goal is to optimize comprehensive breast cancer management, spanning prevention, screening, diagnosis, treatment, and rehabilitation, ultimately improving patient survival and quality of life.

Cancer InnovationVol. 4(5)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), China National Health Development Research Center (CN)
Wenzhou Medical University, Harbin Medical University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Inner Mongolia Medical University, National Natural Science Foundation of China, Sun Yat-sen University, Central South University, Henan University of Science and Technology, Fudan University, Huazhong University of Science and Technology, Kunming Medical University, Jilin University, Ningxia Medical University, Tongji University, Chongqing Medical University, Zhengzhou University, Henan University, Xinjiang Medical University, Chinese Academy of Medical Sciences, University of Electronic Science and Technology of China, Wuhan University, Nanjing Medical University, China Medical University, Peking Union Medical College Hospital, Tianjin Medical University, Qinghai University, Guizhou Medical University, Peking Union Medical College, Qingdao University, Guangxi Medical University, Dalian Medical University, Hebei Medical University, Fujian Medical University, Southwest Medical University, Shandong First Medical University, Second Hospital of Tianjin Medical University, Zhongnan Hospital of Wuhan University, National Science and Technology Major Project, Tongji Medical College, Huazhong University of Science and Technology, Jiangsu Cancer Hospital, Affiliated Hospital of Southwest Medical University, Sun Yat-sen University Cancer Center
Openalex Percentile: Top 63%
Cancer Genomics and Diagnostics
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.